Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Acrivon Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +6 vs. Q4 2023
- Shares held
- 15.2M
- −63.5K (−0.4%) vs. Q4 2023
- Total value
- $109.0M
- +$34.5M (+46.3%) vs. Q4 2023
- New holders
- 12
- 14 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,810,508 | $34.4M | 0.44% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $21.5M | 0.38% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,680,027 | $12.0M | 0.01% | +30,368+1.8% | Added |
| Sands Capital Ventures, LLC | 1,652,605 | $11.8M | 2.85% | 00.0% | Unchanged |
| Wellington Management Group LLP | 888,130 | $6.35M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 743,901 | $5.32M | 0.00% | +178,069+31.5% | Added |
| Marshall Wace, LLP | 597,469 | $4.27M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 507,185 | $3.63M | 0.00% | +31,208+6.6% | Added |
| Geode Capital Management, LLC | 242,846 | $1.74M | 0.00% | +53,646+28.4% | Added |
| State Street Corp | 133,276 | $952.9K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 131,351 | $939.2K | 0.21% | 00.0% | Unchanged |
| UBS Oconnor LLC | 126,949 | $907.7K | 0.03% | +33,506+35.9% | Added |
| Northern Trust Corp | 107,750 | $770.4K | 0.00% | +27,601+34.4% | Added |
| Renaissance Technologies LLC | 102,600 | $734.0K | 0.00% | +102,600 | New |
| Millennium Management LLC | 95,497 | $682.8K | 0.00% | +95,497 | New |
| Charles Schwab Investment Management Inc | 77,382 | $553.3K | 0.00% | +8,881+13.0% | Added |
| Bridgeway Capital Management, LLC | 58,181 | $416.0K | 0.01% | +26,200+81.9% | Added |
| Exchange Traded Concepts, LLC | 56,200 | $401.8K | 0.01% | +42,911+322.9% | Added |
| Baker Bros. Advisors LP | 52,885 | $378.1K | 0.00% | +52,885 | New |
| Bank of New York Mellon Corp | 24,413 | $174.6K | 0.00% | −382−1.5% | Reduced |
| Barclays PLC | 21,324 | $152.5K | 0.00% | −3,160−12.9% | Reduced |
| Morgan Stanley | 17,243 | $123.3K | 0.00% | −8,388−32.7% | Reduced |
| Prelude Capital Management, LLC | 13,000 | $93.0K | 0.01% | +13,000 | New |
| UBS Group AG | 12,745 | $91.1K | 0.00% | +12,745 | New |
| Nuveen Asset Management, LLC | 11,821 | $84.5K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 10,889 | $77.8K | 0.00% | +1,619+17.5% | Added |
| AAFCPAs Wealth Management, LLC | 10,678 | $76.3K | 0.04% | 00.0% | Unchanged |
| Raymond James & Associates | 10,200 | $72.9K | 0.00% | +10,200 | New |
| Bank of America Corp | 6,039 | $43.2K | 0.00% | −4,049−40.1% | Reduced |
| American International Group, Inc. | 6,016 | $43.0K | 0.00% | +1,695+39.2% | Added |
| Advisor Group Holdings, Inc. | 5,080 | $36.3K | 0.00% | +5,080 | New |
| JPMorgan Chase & Co | 4,959 | $35.5K | 0.00% | −28,384−85.1% | Reduced |
| Citigroup Inc | 4,536 | $32.4K | 0.00% | +2,489+121.6% | Added |
| Wells Fargo & Company | 4,299 | $30.7K | 0.00% | +1,608+59.8% | Added |
| New York State Common Retirement Fund | 2,273 | $16.3K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 1,227 | $8.77K | 0.00% | −204−14.3% | Reduced |
| Catalyst Funds Management Pty Ltd | 1,044 | $7.46K | 0.00% | +1,044 | New |
| FMR LLC | 1,027 | $7.34K | 0.00% | +221+27.4% | Added |
| Legal & General Group Plc | 839 | $5.93K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 817 | $5.84K | 0.00% | −1,201−59.5% | Reduced |
| STRS Ohio | 800 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 695 | $4.97K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 378 | $3.00K | 0.00% | −853−69.3% | Reduced |
| Royal Bank of Canada | 278 | $2.00K | 0.00% | −2,210−88.8% | Reduced |
| Russell Investments Group, Ltd. | 223 | $1.59K | 0.00% | +223 | New |
| Avion Wealth | 88 | $1.00K | 0.00% | +88 | New |
| CWM, LLC | 3 | $0 | 0.00% | +3 | New |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | +48 | New |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −430,252−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −226,375−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −46,072−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −31,939−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −13,187−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −260−100.0% | Sold out |